Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to...
Nutrition
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral...
No More Juggling a Dozen Apps — Prevention Now Lives in One Immersive, AI-Powered Experience
Ginkgo Active 4.0 Unlocks Holistic Health Guidance, Making Prevention as Easy as a Daily Check-in VANCOUVER, BC, Aug. 18, 2025...
MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD To Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused On $24.46 Billion Corporate Wellness Market
CLEARWATER, Fla., Aug. 18, 2025 /PRNewswire/ -- MedWell Ai, Inc, ("Company") (OTCQB: MWAI) is pleased to confirm the collaboration and execution...
Virbac:: Paul Martingell’s compensation terms
The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting...
Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona
New Arizona site represents Nutrishare's third pharmacy to support its ability to serve home TPN patients in all 50 states...
Lactéol® diarrhEase™ Launches in the U.S., Bringing Relief for Occasional Diarrhea to Children as Young as Six Months
Clinically studied, drug-free postbiotic now available nationally SHELTON, Conn., Aug. 14, 2025 /PRNewswire/ -- Parents across the U.S. now have...
MyNetDiary Launches PlateAI: The First All-in-One AI-Powered Diet & Wellness App
Smarter, faster, and more personal, PlateAI offers real-time coaching, seamless AI logging, and deep nutrition insights — all in one place...
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately...
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
WESTBROOK, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health...
Parents Urged to Make Kids’ Bedtime Screen-Free as National Campaign Launches with NYC Flash Mob
"Screen-Free Sleep" movement takes to the streets to address America's youth sleep crisis NEW YORK, Aug. 14, 2025 /PRNewswire/ --...
Vitanergy Health US Inc. Launches Three New Dietary Supplements to Support Women’s Daily Wellness
Now available on Amazon, Walmart Marketplace, Flaire.com, and Vitanergy.com—Formulated with high-quality ingredients and made in the USA. LAS VEGAS, Aug....
Protera Health Integrates with Epic to Deliver Seamless Digital MSK Care for Health Plans and Health Systems
DETROIT, Aug. 13, 2025 /PRNewswire/ -- Protera Health, a leading physician-led digital musculoskeletal (MSK) care solution, today announced its integration with...
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",...
Plug and Play Topeka Selects New Cohort of Nine Animal Health Startups for Accelerator Program
Emerging companies from six countries begin the 18-week startup program in Kansas' capital city TOPEKA, Kan., Aug. 13, 2025 /PRNewswire/ -- In...
Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize...
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical...
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical...
Native Hydrate Reviews: Don’t Buy Until You’ve Read This!
NEW YORK, NY / ACCESS Newswire / August 12, 2025 / Forget everything you thought you knew about staying hydrated...
Ivim Health Unveils GLP-1 ID: Precision Dosing Meets Individualized Care
A new standard in GLP-1 therapy that individualizes dosing and patient care for better results, with potentially fewer side effects,...